Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Resverlogix Corp T.RVX

Sector: Healthcare | Sub-Sector: Biotechnology
Alternate Symbol(s):  RVXCF

Resverlogix Corp is a clinical stage cardiovascular company. It is engaged in developing small molecules that selectively inhibit Bromodomain and ExtraTerminal domain (BET) proteins, a new and emerging target for high risk vascular diseases.
Price: $1.63 | Change: +$0.08 | %Change: +5.16%
Volume: 53,330 | Day High/Low: 1.63/1.53 | 52 Week High/Low: 1.93/0.405
View modes: 
0 stars

RE:RE:RE:RE:RE:RE:RE:RE:Analyst Report: Interesting Passage

SanFran: I forgot to mention, that going forward  I'm buying the dips a bit at a time, all the way to the finish line.  G1945V  rate and reply
0 stars

RE:RE:RE:RE:RE:RE:RE:Analyst Report: Interesting Passage

SanFran: The only thing I interpret from all of this, is. that RVX is finally picking up traction. It is what it is. At this stage of the game. we either believe in it or we don't. The science is very...read more
0 stars

RE:RE:RE:RE:RE:RE:Analyst Report: Interesting Passage

Hi GV:  Well, it is all a little obtuse, so I think it is open to different interpretations.  No doubt about that!    ( :  My take is that it might be saying that they have done a lot of research...read more
0 stars

RE:RE:RE:RE:RE:Analyst Report: Interesting Passage

Hello again SanFran: I read over that part of the report and the closest I come to understand what is meant by what is termed as nexus of pathways, is the Phase 3 Orphan Indications that will be...read more
3 stars

RE:RE:RE:RE:Analyst Report: Interesting Passage

Hi GV:  Apologies for not listing the page number that time for the quote.  It is on page 22-23 of the report.  rate and reply
0 stars

RE:RE:RE:Analyst Report: Interesting Passage

SanFran: What page?  rate and reply
3 stars

RE:RE:Analyst Report: Interesting Passage

Hi G.V.:  I think that's reasonable... but if you look at my other post on the subject (sent just after you did yours), I think it is more than that.  Sounds like they have more information about the...read more
3 stars

RE:Analyst Report: Interesting Passage

This is another interesting passage from the analyst report (highlighting added by me): Emerging in Resverlogix’s data is a new nexus of pathways and biology’s that appear to be...read more
1 star

RE:Analyst Report: Interesting Passage

Sanfran: My kick at the can....  :) IMO all this says is what we have have talking about on this BB the last couple of weeks or so.   The novel approach referenced would be the... PCSK9...read more
3 stars

Analyst Report: Interesting Passage

The following is an interesting passage from the recent analyst report on Resverlogix.  I've added some highlighting to underscore some interesting parts - I wonder what they are referring to: ...read more
0 stars

RE:SIDE NOTE OF POTENTIAL ON A SLOW DAY

Slow in the pinks: Resverlogix Corp.   Ordinary SharesInternational Reporting OTC Pink Current Information  1.27060.0294 (2...read more
5 stars

SIDE NOTE OF POTENTIAL ON A SLOW DAY

FYI for those of interest: March 27, 2015  By Mark Terry, BioSpace.com Breaking News Staff  Loos, France-based Genfit (GNFTF), whose U.S. headquarters are in Cambridge, Mass., announced yesterday...read more
5 stars

RE:RE:Science

prince: we all take risks waking up in the morning , crossing the street,  to get a cup of coffee at Tim Horton's ..:) G1945V  rate and reply
1 star

RE:Science

anthony, you seem like an honest but confused poster...no retail owner of RVX can be compared to Dart and to do so is just idiotic... tell me have you read anything about Dart's rights related to loan...read more
5 stars

Chart looking very positive to my eyes....

Big volume pushed us almot to $2.00...and while we've given some of that back, in the grand scheme of things we haven't fall back much.  It looks to me like we're climbing the ladder....from 50 cents...read more
5 stars

Science

I know nothing of the science.I do know finance and have dealt with very wealthy client all my business life.There are consistent traits in almost all wealthy persons,the biggest of these is the...read more
5 stars

RE:RE:RE:DR WONG AT EAS SCOTLAND

Thx so much for your response. I really appreciate both you and bfw taking the time to think this thru. I'm also into a similar situation called BIND, A NASDAQ LISTED drug candidate involved with...read more
5 stars

RE:RE:DR WONG AT EAS SCOTLAND

Hi Ron, I tend to disagree with your friend. I have spent a long time trying to understand how RVX-208 might work. I have screened hundreds of articles on the abstract level and read more than 50 of...read more
1 star

SLOW TRADING DAY- 0 TRADES IN THE PINKS SO FAR

Is it that the longs do not want to share? 😀 Resverlogix Corp.   Ordinary SharesInternational Reporting OTC Pink Current Information  ...read more
4 stars

RE:RE:RE:DR WONG AT EAS SCOTLAND

Thanks for a great post bfw, further to your third paragraph; when I asked RVX questions regarding the topics of target market, pricing and payor acceptance I was told that if RVX could replicate the...read more